Efficacy, Safety, and Pharmacokinetics of QAW039

Clinical trial NCT01253603 · COMPLETED

Trial details

NCT number: NCT01253603
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Persistent Asthma

Start date: 2010-11-01
Primary completion: 2011-09-01
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.